Cargando…
Optimizing Outcomes in Immunocompromised Hosts: Understanding the Role of Immunotherapy in Invasive Fungal Diseases
A major global concern is the emergence and spread of systemic life-threatening fungal infections in critically ill patients. The increase in invasive fungal infections, caused most commonly by Candida and Aspergillus species, occurs in patients with impaired defenses due to a number of reasons such...
Autores principales: | Ravikumar, Sharada, Win, Mar Soe, Chai, Louis Yi Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660869/ https://www.ncbi.nlm.nih.gov/pubmed/26635780 http://dx.doi.org/10.3389/fmicb.2015.01322 |
Ejemplares similares
-
Tocilizumab Induces IL-10-Mediated Immune Tolerance in Invasive Candidiasis
por: Tan, Zhaohong, et al.
Publicado: (2021) -
Editorial: Invasive fungal disease in the immunocompromised host/Research Topic proceedings of the mycology 2021 meeting
por: Agrawal, Samir, et al.
Publicado: (2022) -
Challenges in the Diagnosis of Invasive Fungal Infections in Immunocompromised Hosts
por: Antinori, Spinello, et al.
Publicado: (2018) -
Radionuclide Imaging of Invasive Fungal Disease in Immunocompromised Hosts
por: Lawal, Ismaheel O., et al.
Publicado: (2021) -
Cutaneous fungal infection in an immunocompromised host
por: Sotello, David, et al.
Publicado: (2017)